Financial overview

Modus Therapeutics financial report data and keyfigures. History for income statement, balance sheet and cash flow.

Pre
Pre
Pre

Description

Modus is a clinical biotechnology company that, through the patented polysaccharide sevuparin, is developing a treatment for sepsis and septic shock (blood poisoning). Behind the Company's operations is over 20 years of research on the positive mechanisms of action of sevuparin. By ensuring that sevuparin can be prescribed in several times higher doses than comparable polysaccharides, the harmful processes in the body that occur during sepsis could be stopped and septic shock could be prevented.

Biotechnology